References - Homocysteine in Protein Structure/Function and Human Disease - page 143

242. Crepin T, Schmitt E, Mechulam Y, Sampson PB, Vaughan MD, Honek JF, et al. Use of
analogues of methionine and methionyl adenylate to sample conformational changes during
catalysis in Escherichia coli methionyl-tRNA synthetase. J Mol Biol. 2003;332(1):59-72.
243. Jakubowski H. Proofreading in trans by an aminoacyl-tRNA synthetase: a model for single
site editing by isoleucyl-tRNA synthetase. Nucleic Acids Res. 1996;24(13):2505-10.
244. Jakubowski H. Synthesis of cysteine-containing dipeptides by aminoacyl-tRNA synthetases.
Nucleic Acids Res. 1995;23(22):4608-15.
245. Jakubowski H. Amino acid selectivity in the aminoacylation of coenzyme A and RNA
minihelices by aminoacyl-tRNA synthetases. J Biol Chem. 2000;275(45):34845-8.
246. Mocibob M, Ivic N, Bilokapic S, Maier T, Luic M, Ban N, et al. Homologs of aminoacyl-
tRNA synthetases acylate carrier proteins and provide a link between ribosomal and
nonribosomal peptide synthesis. Proc Natl Acad Sci USA. 2010;107(33):14585-90.
247. Jarvis D, Bondanszky M, du Vigneaud V. The synthesis of 1-(hemi-homocysteine)-oxytocin
and a study of some of its pharmacological properties. J Am Chem Soc. 1961;83:4780-4.
248. Daruzzaman A, Clifton IJ, Adlington RM, Baldwin JE, Rutledge PJ. The crystal structure of
isopenicillin N synthase with a dipeptide substrate analogue. Arch Biochem Biophys.
2013;530(1):48-53.
249. Lima B, Forrester MT, Hess DT, Stamler JS. S-nitrosylation in cardiovascular signaling. Circ
Res. 2010;106(4):633-46.
250. Perla-Kajan J, Jakubowski H. Paraoxonase 1 protects against protein N-homocysteinylation
in humans. FASEB J. 2010;24(3):931-6.
251. Suszynska J, Tisonczyk J, Lee HG, Smith MA, Jakubowski H. Reduced homocysteine-
thiolactonase activity in Alzheimer's disease. J Alzheimers Dis. 2010;19(4):1177-83.
252. Marsillach J, Mackness B, Mackness M, Riu F, Beltran R, Joven J, et al. Immunohistochemi-
cal analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol
Med. 2008;45(2):146-57.
253. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, et al. Mice lacking serum paraoxonase
are susceptible to organophosphate toxicity and atherosclerosis. Nature. 1998;394
(6690):284-7.
254. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang RL, Yang X, Schmitt D, et al. Relationship of
paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative
stress and cardiovascular risk. JAMA. 2008;299(11):1265-76.
255. Bayrak A, Bayrak T, Tokgozoglu SL, Volkan-Salanci B, Deniz A, Yavuz B, et al. Serum
PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis. J
Atheroscler Thromb. 2012;19(4):376-84.
256. Jakubowski H. Paraoxonase 1 (PON1), a Junction between the metabolisms of homocysteine
and lipids. In: Mackness B, Mackness M, Aviral M, Paragh G, editors. Proteins and cell
regulation, vol. 6. Dordrecht: Springer; 2008. p. 87-102.
257. Perla-Kajan J, Jakubowski H. Paraoxonase 1 and homocysteine metabolism. Amino Acids.
2012;43(4):1405-17.
258. Dantoine TF, Debord J, Merle L, Lacroix-Ramiandrisoa H, Bourzeix L, Charmes
JP. Paraoxonase 1 activity: a new vascular marker of dementia? Ann N Y Acad Sci.
2002;977:96-101.
259. Paragh G, Balla P, Katona E, Seres I, Egerhazi A, Degrell I. Serum paraoxonase activity
changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry
Clin Neurosci. 2002;252(2):63-7.
260. Erlich PM, Lunetta KL, Cupples LA, Abraham CR, Green RC, Baldwin CT, et al. Serum
paraoxonase activity is associated with variants in the PON gene cluster and risk of
Alzheimer disease. Neurobiol Aging. 2012;33(5):1015.e7-1015.e23.
261. Lacinski M, Skorupski W, Cieslinski A, Sokolowska J, Trzeciak WH, Jakubowski H.
Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein
in humans. Cell Mol Biol (Noisy-le-Grand). 2004;50(8):885-93.